Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Acute kidney injury
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Injury or Poisoning
|
185
|
3
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Kidney Failure, Acute
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
826
|
32
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute Kidney Insufficiency
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
104
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Myocardial Reperfusion Injury
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
226
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
420
|
15
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.080 |
None |
1.000 |
8 |
|
2012 |
2017 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.050 |
None |
1.000 |
5 |
1
|
2011 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.050 |
None |
1.000 |
5 |
1
|
2012 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.050 |
None |
1.000 |
5 |
|
2012 |
2019 |
Ankylosing spondylitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
710
|
609
|
0.040 |
None |
1.000 |
4 |
|
2013 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.040 |
None |
1.000 |
4 |
1
|
2012 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.030 |
None |
1.000 |
3 |
|
2012 |
2018 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.020 |
None |
1.000 |
2 |
1
|
2014 |
2016 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.020 |
None |
1.000 |
2 |
1
|
2014 |
2016 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.020 |
None |
1.000 |
2 |
1
|
2014 |
2016 |